Regenerative Endodontic Therapy in Cases of Irreversible Pulpitis
Root canal therapy (RCT) is a classical and effective treatment that is currently utilised in dental practice, offering high success rates for pulp and periapical diseases; however, teeth after RCT are susceptible to altered pulp defence and sensory function, even fractures, as a consequence of pulp loss. Furthermore,
| Condition(s) | Symptomatic Irreversible Pulpitis |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Root canal therapy (RCT) is a classical and effective treatment that is currently utilised in dental practice, offering high success rates for pulp and periapical diseases; however, teeth after RCT are susceptible to altered pulp defence and sensory function, even fractures, as a consequence of pulp loss. Furthermore, several studies have highlighted that the actual failure rate of standard root canal treatments performed in general practice is significantly higher than expected . Moreover, these treatments are lengthy and costly and are often subject to retreatment .Inherent in this procedure(rct) is loss of dental hard tissue and subsequent weakening of the treated tooth,making them more prone to fracture. Therefore, less invasive alternative strategies could be used to treat pulpitis, e |
| Who can participate | Inclusion Criteria: * Patients from both genders with an age range of 18-35 years old. * Permanent teeth with mature roots with a diagnosis of irreversible pulpitis, with absorption damage to the apex, and the diameter of the apical hole is greater than 1 mm. * A restorable tooth. * There is no need to leave space for the final post/core restoration. * Anterior teeth and premolars with single canal. * A cooperative and compliant patient. * Patients not allergic to the drugs and antibiotics which needed to complete treatment. * No periodontal disease or root cracking. Exclusion Criteria: * Patients with other serious organ diseases, such as cardiopulmonary, kidney and other major diseases. * Pregnant women or lactating or expecting within a year. * Patients with apical cysts. * Patients wit |
| Ages | 18 Years to 35 Years |
| Sex | All |
| Lead sponsor | Shaheed Zulfiqar Ali Bhutto Medical University |
| Locations | Islamabad, ICT, Pakistan |
| Start date | 2024-08-01 |
| NCT ID | NCT06525844 |
| Official listing | https://clinicaltrials.gov/study/NCT06525844 |